Milestone Scientific (NYSE:MLSS) Earns Hold Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Milestone Scientific (NYSE:MLSS) in a research report report published on Wednesday. The brokerage issued a hold rating on the stock.

Milestone Scientific Stock Performance

NYSE MLSS opened at $0.90 on Wednesday. Milestone Scientific has a fifty-two week low of $0.54 and a fifty-two week high of $1.39. The stock has a market cap of $70.18 million, a P/E ratio of -12.87 and a beta of 1.12. The stock has a 50 day simple moving average of $0.99 and a two-hundred day simple moving average of $0.96.

Institutional Investors Weigh In On Milestone Scientific

Several institutional investors and hedge funds have recently modified their holdings of MLSS. World Investment Advisors LLC bought a new position in Milestone Scientific in the third quarter worth about $91,000. Renaissance Technologies LLC lifted its stake in shares of Milestone Scientific by 72.8% in the 4th quarter. Renaissance Technologies LLC now owns 126,275 shares of the company’s stock valued at $121,000 after purchasing an additional 53,198 shares during the period. Y Intercept Hong Kong Ltd bought a new stake in shares of Milestone Scientific during the third quarter valued at approximately $48,000. Geode Capital Management LLC grew its stake in Milestone Scientific by 6.4% in the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after purchasing an additional 31,572 shares during the period. Finally, Carnegie Investment Counsel raised its holdings in Milestone Scientific by 18.9% in the fourth quarter. Carnegie Investment Counsel now owns 172,609 shares of the company’s stock worth $166,000 after purchasing an additional 27,412 shares in the last quarter. 5.79% of the stock is owned by hedge funds and other institutional investors.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.